p53-Independent caspase-mediated apoptosis in human leukaemic cells is induced by a DNA minor groove binder with antineoplastic activity

Apoptosis

Volumn 4, Issue 1, 1999, Pages 39-45

  Marchini, S ^a   Ciro', M ^a   Broggini, M ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Apoptosis; Caspases; Leukaemic cells; Minor groove binders

Indexed keywords

ALPHA BROMOACRYLOYL DISTAMYCIN; CASPASE; DISTAMYCIN A DERIVATIVE; PNU 151807; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; DNA CLEAVAGE; DRUG DNA BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULAR RECOGNITION; PRIORITY JOURNAL;

EID: 0032787292     PISSN: 13608185     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009630132087     Document Type: Article

References (15)

1. D'Alessio R, Geroni C, Biasoli G, Pesenti E, Grandi M, Mongelli N. Structure activity relationship of novel distamycin A derivatives: synthesis and antitumour activity. Bioorganic Med Chem Lett 1994; 4: 1467-1472.
2. Marchini S, Ciro M, Gallinari F, et al. α-bromoacryloyl derivative of distamycin A (PNU 151807): a new non covalent minor groove DNA binder with antineoplastic activity. Br J Cancer 1999 (in press).
3. Hurley LH, Reynolds VL, Swenson DH, Petzold GL, Scahill TA. Reaction of the antitumoural antibiotic CC-1065 with DNA: structure of DNA adduct with sequence specificity. Science 1984; 226: 843-844.
4. Broggini M, Erba E, Ponti M, et al. Selective DNA interaction of the novel distamycin derivative FCE 24517. Cancer Res 1991; 51: 199-204.
5. Geroni C, Pesenti E, Tagliabue G, et al. Establishment of L1210 leukemia cells resistant to the distamycin-A derivative (FCE 24517): characterization and cross-resistance studies. Int J Cancer 1993; 53: 308-314.
6. Shao RG, Shimizu T, Pommier Y. 7-Hydroxystaurosporine (UCN-01) induces apoptosis in human colon carcinoma and leukemia cells independently of p53. Exper Cell Res 1997; 234: 388-397.
7. Vikhanskaya F, Vignati S, Beccaglia P, et al. Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis. Exper Cell Res 1998; 241: 96-101.
8. Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Cancer Res 1996; 56: 4743-4748.
9. Martins LM, Mesner PW, Kottke T, et al. Comparison of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 1997; 11: 4283-4296.
10. Sambrook J, Fritsh E, Maniatis T. Molecolar Cloning: A Laboratory Manual. Cold Spring Harbor, NY USA: Cold Spring Harbor Laboratory Press, 1989.
11. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actincleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 1996; 56: 5224-5229.
12. Miossec C, Duttileul V, Fassy F, Hercend AD. Evidence for CPP32 activation in the absence of apoptosis during T-lymphocyte stimulation. J Biolog Chem 1997; 272: 13459-13462.
13. Blagosklonny MV, Schulte TW, Nguyen P, Trepel J, Neckers L. Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-raf-1 and represents a novel c-raf-1 signal transduction pathway. Cancer Res 1996; 56: 1851-1854.
14. Broggini M, Coley HM, Mongelli N, et al. DNA sequence-specific adenine alkylation by the novel antitumour drug tallumustine (FCE 24517), a benzoyl nitrogen mustard derivative of distamycin. Nucleic Acid Res 1995; 23: 81-87.
15. Suzuki A, Kato M. Chemotherapeutic agent CPT-11 induces the new expression of the apoptosis initiator to the cytoplasm. Exper Cell Res 1996; 227: 154-159.